Clinical Trial Update: A Clinical Study of 68Ga-HX01 Injection for PET Imaging [Phase 1]

View source ↗

Summary

Phase 1 clinical study of the PET imaging agent 68Ga-HX01 has been completed in healthy volunteers and patients with malignancy.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cancer

Drugs mentioned

• 68Ga-HX01 Injection

Snippet

Sponsor: Hexin (Suzhou) Pharmaceutical Technology Co., Ltd | Conditions: Healthy, Malignancy | Phase 1 | Status: COMPLETED